Consensus on resectability in N3 head and neck squamous cell carcinomas: GETTEC recommendations.
Fiche publication
Date publication
avril 2020
Journal
Oral oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GALLET Patrice
Tous les auteurs :
Carsuzaa F, Gorphe P, Vergez S, Malard O, Fakhry N, Righini C, Philouze P, Lasne-Cardon A, Gallet P, Tonnerre D, Bozec A, de Mones E, Baujat B, Laccourreye L, Babin E, Dufour X, Thariat J
Lien Pubmed
Résumé
Among patients with T0-2 N3 head and neck squamous cell carcinomas (HNSCC), those undergoing upfront neck dissection have better oncological outcomes. However, there is no consensual definition of disease resectability of N3 nodes, leading to major treatment attrition and interpretation biases between studies. We established a Delphi method-based consensus to define resectability and impact on decision-making for upfront neck dissection in N3 patients.
Mots clés
Cervical nodes, Chemoradiation, Contraindication, Head and neck squamous cell carcinoma, Neck dissection, Surgery
Référence
Oral Oncol.. 2020 Apr 23;106:104733